There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September…
In Conversation
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the…
Recordati was created in 1926, and the combined work of three generations turned the small laboratory not only into a local success story but also a…
The acquisition of Jerini has to be one of the biggest milestones for Shire Deutschland in its recent history. How have the synergies developed between the…
You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and…
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French…
Roche, once a true pharmaceutical company, is now recognized by its capacity to create a unique business model that allowed to become the world’s largest biotech…
Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent…
